14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Tuesday, 7th May 2024 CGEN stock ended at $2.21. This is 2.79% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 5.40% from a day low at $2.13 to a day high of $2.25.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Compugen Ltd. prices

Date Open High Low Close Volume
Feb 27, 2023 $0.760 $0.790 $0.750 $0.762 308 325
Feb 24, 2023 $0.737 $0.778 $0.680 $0.745 303 009
Feb 23, 2023 $0.784 $0.791 $0.750 $0.750 275 609
Feb 22, 2023 $0.780 $0.799 $0.759 $0.792 156 082
Feb 21, 2023 $0.790 $0.81 $0.750 $0.750 565 271
Feb 17, 2023 $0.80 $0.85 $0.780 $0.81 617 989
Feb 16, 2023 $0.80 $0.87 $0.790 $0.790 302 246
Feb 15, 2023 $0.84 $0.84 $0.781 $0.81 341 983
Feb 14, 2023 $0.81 $0.86 $0.793 $0.83 503 753
Feb 13, 2023 $0.84 $0.85 $0.780 $0.780 290 755
Feb 10, 2023 $0.81 $0.89 $0.80 $0.82 785 792
Feb 09, 2023 $0.86 $0.86 $0.710 $0.790 766 945
Feb 08, 2023 $0.94 $0.94 $0.84 $0.84 1 032 645
Feb 07, 2023 $0.97 $0.97 $0.94 $0.94 380 464
Feb 06, 2023 $0.96 $1.01 $0.94 $0.98 343 659
Feb 03, 2023 $1.01 $1.10 $0.96 $0.96 1 012 124
Feb 02, 2023 $0.91 $1.09 $0.88 $0.99 1 894 476
Feb 01, 2023 $0.85 $0.94 $0.84 $0.87 630 756
Jan 31, 2023 $0.88 $0.90 $0.84 $0.87 426 889
Jan 30, 2023 $0.88 $0.89 $0.84 $0.86 316 235
Jan 27, 2023 $0.85 $0.89 $0.85 $0.87 436 539
Jan 26, 2023 $0.87 $0.89 $0.84 $0.87 242 142
Jan 25, 2023 $0.88 $0.88 $0.81 $0.88 445 616
Jan 24, 2023 $0.84 $0.91 $0.84 $0.88 672 778
Jan 23, 2023 $0.85 $0.87 $0.83 $0.86 947 152
Click to get the best stock tips daily for free!

About Compugen Ltd.

Compugen Ltd. Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I clinical study in patients wi... CGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT